Global Reach Dako, under Agilent Technologies, serves hospitals and research labs worldwide, showcasing a potential for global sales expansion.
High Revenue Range With a revenue in the range of $100 million to $1 billion, Dako presents significant sales potential for high-value deals.
Competitive Landscape In comparison to similar companies like Roche and Thermo Fisher Scientific, Dako stands out as a unique sales proposition in the industry.
Medical Equipment Demand As a medical equipment manufacturer, Dako taps into the growing demand for advanced pathology solutions, indicating a strong sales market.
Industry Expertise Dako's expertise in providing pathology solutions for cancer diagnosis positions the company as a go-to option for healthcare institutions, offering a clear sales opportunity.
93K
$1B
2.4K$1B
672$100M$1B
5.4K$1B
244$10M$50M
10K$1B
95K$1B| Dako Email Formats | Percentage |
| First.Last@dako.com | 88% |
| FLast@dako.com | 7% |
| Last@dako.com | 4% |
| First-Last@dako.com | 1% |
Medical Equipment ManufacturingGlostrup, Denmark1001-5000 Employees
Dako is owned by Agilent Technologies. Hospitals and research laboratories worldwide use Agilent's Dako brand of pathology solutions, including reagents, instruments, software and expertise, to make accurate tissue-based diagnoses and determine the most effective treatment for cancer patients. www.dako.com
Company Overview
Funding & FinancialsDako's revenue is in the range of $100M$1B
Funding & FinancialsDako's revenue is in the range of $100M$1B
1-888-653-2347 
support@leadiq.com